Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies
Siwińska-Gołebiowska, H.; Czerwińska-Kartowicz, I.; Markiewicz, K.
Postepy Higieny i Medycyny Doswiadczalnej 56 Suppl: 33-40
2002
ISSN/ISBN: 0032-5449 PMID: 12661412 Document Number: 541880
The rules and own authors experience according preventive and curative using of intravenous immunoglobulins (IVIG) in children with primary cellular immunodeficiency is presented.
Document emailed within 1 workday
Related Documents
Sapir, T.; Carp, H.; Shoenfeld, Y. 2005: Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL) Harefuah 144(6): 415Lewandowicz-Uszyńska, A.; Jankowski, A. 2011: The use of intravenous immunoglobulins in the treatment of primary immunodeficiencies Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 30(180): 409-412
Sbrana, S.; Ruocco, L.; Vanacore, R.; Azzarà, A.; Ambrogi, F. 1993: In vitro effects of an immunoglobulin preparation for intravenous use (IVIG) on T-cells activation Allergie et Immunologie 25(1): 35-37
Maksymowych, W.P.; Aviña-Zubieta, A.; Luong, M.; Russell, A.S. 1996: High dose intravenous immunoglobulin (IVIg) in severe refractory rheumatoid arthritis: no evidence for efficacy Clinical and Experimental Rheumatology 14(6): 657-660
Nydegger, U.E. 1983: Evaluation criteria for intravenous immunoglobulin G preparations Presse Medicale 12(41): 2619-2624
Rüfenacht, R.; Morell 1991: Immunochemical characterization of intravenous immunoglobulin preparations Allergologia et Immunopathologia 19(5): 197-200
Guencheva, G. 1984: Requirements and characteristics of various immunoglobulin preparations for intravenous application Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 30(1): 21-23
Stephan, W.; Dichtelmüller, H. 1983: Beta-propiolactone as a sterilizing agent in the manufacture of intravenous immunoglobulin preparations Arzneimittel-Forschung 33(9): 1230-1231
Kiseleva, I.A.; Anastasiev, V.V.; Novikova, L.P.; Voronova, E.A.; Kartavina, G.I. 1990: Elaboration of the technology of producing a lyophilized form of immunoglobulin preparations for intravenous administration Gematologiia i Transfuziologiia 35(5): 32-34
Sirianni, M.C.; Pucillo, L.P.; Fiorilli, M.; Aiuti, F.; Banck, G.; Forsgren, A. 1981: Formalin-treated bacteria as selective B cell mitogens: results in primary and acquired immunodeficiencies Clinical and Experimental Immunology 45(2): 393-398
Gary-Crosier, F.; Nydegger, U.; Villard, J. 2009: Can we do without intravenous polyclonal immunoglobines (IVIg)? Revue Medicale Suisse 5(199): 819-822
Haymann, J.P.; Glotz, D. 1999: Intravenous polyclonal immunoglobulins (IVIG): what use in transplantation? Nephrologie 20(3): 139-143
Gerber, B.; Steger, A.; Haessig, M.; Glaus, T.M. 2002: Use of human intravenous immunoglobulin in dogs with primary immune mediated hemolytic anemia Schweizer Archiv für Tierheilkunde 144(4): 180-185
Nürnberger, W.; Willers, R.; Körholz, D.; Göbel, U.; Wahn, V. 1988: Preventive long-term intravenous immunoglobulin infusion in children with acute lymphatic leukemia. I. Anticomplementary activity of gamma globulin preparations is a function of the preparation and IgG concentration prior to infusions Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 136(3): 116-120
Freud, C. 2001: Patients with immunodeficiencies regularly attend for immunoglobulin infusions Nursing Times 97(20): 42
Ricci, C.; Minetto, E.; Cascio, G.; De Stefano, A.; Basso, M.; Borelli, P.; Bozzone, D.; Delia, D.; Baldassi, R. 1984: Normalization of electrophoretic mobility of lymphocytes in patients with primary immunoglobulin deficiency treated with intravenous immunoglobulins Acta Medica Hungarica 41(4): 297-302
Abrahamsen, T.G.; Sandersen, H.; Bustnes, A. 1996: Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies Pediatrics 98(6 Pt 1): 1127-1131
Steinmuller, D.R.; Graneto, D.; Swift, C.; Novick, A.C.; Streem, S.B.; Cunningham, R.J.; Hodge, E.; Bretan, P. 1989: Use of intravenous immunoglobulin prophylaxis for primary cytomegalovirus infection post living-related-donor renal transplantation Transplantation Proceedings 21(1 Pt 2): 2069-2071
Gadoth, N.; Melamed, E.; Miller, A.; Steiner, I.; Abramsky, O. 1999: Intravenous immunoglobulin treatment in multiple sclerosis Neurology 52(1): 214-215
Taneichi, H.; Miyawaki, T. 2011: High-dose intravenous immunoglobulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 69(3): 515-519